These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35020865)

  • 1. Patho-immunological mechanisms of vitiligo: the role of the innate and adaptive immunities and environmental stress factors.
    Faraj S; Kemp EH; Gawkrodger DJ
    Clin Exp Immunol; 2022 Jan; 207(1):27-43. PubMed ID: 35020865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives of New Advances in the Pathogenesis of Vitiligo: From Oxidative Stress to Autoimmunity.
    Wang Y; Li S; Li C
    Med Sci Monit; 2019 Feb; 25():1017-1023. PubMed ID: 30723188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitiligo: An immune disease and its emerging mesenchymal stem cell therapy paradigm.
    Zhang M; Xia T; Lin F; Yu J; Yang Y; Lei W; Zhang T
    Transpl Immunol; 2023 Feb; 76():101766. PubMed ID: 36464219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitiligo Pathogenesis and Emerging Treatments.
    Rashighi M; Harris JE
    Dermatol Clin; 2017 Apr; 35(2):257-265. PubMed ID: 28317534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immune mechanisms in vitiligo: danger from within.
    Richmond JM; Frisoli ML; Harris JE
    Curr Opin Immunol; 2013 Dec; 25(6):676-82. PubMed ID: 24238922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment update for vitiligo based on autoimmune inhibition and melanocyte protection.
    Xie B; Zhu Y; Shen Y; Xu W; Song X
    Expert Opin Ther Targets; 2023 Mar; 27(3):189-206. PubMed ID: 36947026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitiligo: How do oxidative stress-induced autoantigens trigger autoimmunity?
    Xie H; Zhou F; Liu L; Zhu G; Li Q; Li C; Gao T
    J Dermatol Sci; 2016 Jan; 81(1):3-9. PubMed ID: 26387449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Concise Review on the Role of Endoplasmic Reticulum Stress in the Development of Autoimmunity in Vitiligo Pathogenesis.
    Jadeja SD; Mayatra JM; Vaishnav J; Shukla N; Begum R
    Front Immunol; 2020; 11():624566. PubMed ID: 33613564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitiligo: interplay between oxidative stress and immune system.
    Laddha NC; Dwivedi M; Mansuri MS; Gani AR; Ansarullah M; Ramachandran AV; Dalai S; Begum R
    Exp Dermatol; 2013 Apr; 22(4):245-50. PubMed ID: 23425123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Innate Immunity to Combat Cutaneous Stress: The Vitiligo Perspective.
    Boniface K; Passeron T; Seneschal J; Tulic MK
    Front Immunol; 2021; 12():613056. PubMed ID: 33936032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity?
    Garbelli S; Mantovani S; Palermo B; Giachino C
    Pigment Cell Res; 2005 Aug; 18(4):234-42. PubMed ID: 16029417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trained immunity in the pathogenesis of vitiligo.
    Post NF; Ginski G; Peters R; Van Uden NOP; Bekkenk MW; Wolkerstorfer A; Netea MG; Luiten RM
    Pigment Cell Melanoma Res; 2023 Sep; 36(5):348-354. PubMed ID: 37293969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Features, Immunopathogenesis, and Therapeutic Strategies in Vitiligo.
    Wang Y; Li S; Li C
    Clin Rev Allergy Immunol; 2021 Dec; 61(3):299-323. PubMed ID: 34283349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the pathogenesis of vitiligo.
    Marchioro HZ; Silva de Castro CC; Fava VM; Sakiyama PH; Dellatorre G; Miot HA
    An Bras Dermatol; 2022; 97(4):478-490. PubMed ID: 35643735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The enigma and challenges of vitiligo pathophysiology and treatment.
    Abdel-Malek ZA; Jordan C; Ho T; Upadhyay PR; Fleischer A; Hamzavi I
    Pigment Cell Melanoma Res; 2020 Nov; 33(6):778-787. PubMed ID: 32198977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitiligo as an inflammatory skin disorder: a therapeutic perspective.
    Taïeb A
    Pigment Cell Melanoma Res; 2012 Jan; 25(1):9-13. PubMed ID: 22099450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of melanocyte death in vitiligo.
    Chen J; Li S; Li C
    Med Res Rev; 2021 Mar; 41(2):1138-1166. PubMed ID: 33200838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Oxidative Stress in Vitiligo: An Update on Its Pathogenesis and Therapeutic Implications.
    Chang WL; Ko CH
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines: the yin and yang of vitiligo pathogenesis.
    Singh M; Kotnis A; Jadeja SD; Mondal A; Mansuri MS; Begum R
    Expert Rev Clin Immunol; 2019 Feb; 15(2):177-188. PubMed ID: 30462555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research progress of vitiligo repigmentation: from oxidative stress to autoimmunity.
    Yu T; Wu Y; Lu Z
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):147-151. PubMed ID: 38678613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.